Cargando…

(18)F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with (223)Ra-chloride (Alpharadin)

BACKGROUND: A qualitative assessment of conventional bone scintigraphy with (99m)Tc methylene diphosphonate is perceived as an insensitive method for monitoring the treatment response of bone metastases, and we postulated that semi-quantitative (18)F-fluoride positron emission tomography (PET) might...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cook, Gary JR, Parker, Chris, Chua, Sue, Johnson, Bernadette, Aksnes, Anne-Kirsti, Lewington, Val J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2011
Materias:	Preliminary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192465/ https://www.ncbi.nlm.nih.gov/pubmed/22214491 http://dx.doi.org/10.1186/2191-219X-1-4

Ejemplares similares

Ultrastructural changes in the cemento-enamel junction after vital tooth bleaching with fluoride and fluoride-free agents – a pilot study
por: Gasic, Jovanka, et al.
Publicado: (2012)

Ra223 in Bone Metastases with Osteolytic Activity
por: Costa, Renato Patrizio, et al.
Publicado: (2018)

Circulating tumor cells and γH2AX as biomarkers for responsiveness to radium-223 in advanced prostate cancer patients
por: Chatzkel, Jonathan, et al.
Publicado: (2019)

Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer: Practical Management Issues for Patient Selection
por: Den, Robert B., et al.
Publicado: (2019)

Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [(223)Ra]RaCl(2) therapy
por: Sraieb, Miriam, et al.
Publicado: (2020)

(18)F-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myeloma
por: Regelink, J. C., et al.
Publicado: (2016)

Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
por: Du, Yong, et al.
Publicado: (2017)

Synthesis of indolo[3,2-b]carbazole-based new colorimetric receptor for anions: A unique color change for fluoride ions
por: Mahapatra, Ajit Kumar, et al.
Publicado: (2010)

Consensus molecular subtypes of primary colon tumors and their hepatic metastases
por: Lau, Yee Chen, et al.
Publicado: (2021)

A convenient catalyst system for microwave accelerated cross-coupling of a range of aryl boronic acids with aryl chlorides
por: Clarke, Matthew L, et al.
Publicado: (2007)

Assessment of bone graft incorporation by (18) F-fluoride positron-emission tomography/computed tomography in patients with persisting symptoms after posterior lumbar interbody fusion
por: Brans, Boudewijn, et al.
Publicado: (2012)

Negative contrast Cerenkov luminescence imaging of blood vessels in a tumor mouse model using [(68)Ga]gallium chloride
por: Steinberg, Jeffrey D, et al.
Publicado: (2014)

Development of CNS metastases in breast cancer patients treated with curative intent: a case–control study
por: Chakrabarti, Katherine, et al.
Publicado: (2020)

Radium-223 for the Management of Bone Metastases in Castration-Resistant Prostate Cancer
por: Cox, Heather, et al.
Publicado: (2015)

Response to (223)Ra-dichloride in castration-resistant prostate cancer with bone metastasis: A case report
por: Cabrera, Montserrat Estorch, et al.
Publicado: (2016)

Treatment of castration-resistant prostate cancer and bone metastases with radium-223 dichloride
por: Lien, Lise Marie E, et al.
Publicado: (2015)

Dosimetry-Based Consideration on Remission and Relapse after Therapy with (223)Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case Report
por: Mangano, Anna Maria, et al.
Publicado: (2018)

Fc-engineered monoclonal antibodies to reduce off-target liver uptake
por: Mangeat, Tristan, et al.
Publicado: (2023)

Radiopharmacokinetic modelling and radiation dose assessment of (223)Ra used for treatment of metastatic castration-resistant prostate cancer
por: Höllriegl, Vera, et al.
Publicado: (2021)

Laser isotope separation of (223)Ra
por: Suryanarayana, M. V.
Publicado: (2023)

Radium-223 Chloride: A New Treatment Option for Metastatic Castration-Resistant Prostate Carcinoma
por: Pinto, Álvaro, et al.
Publicado: (2012)

Fine Structures in $^{14}C$ Emission of $^{223}Ra$ and $^{224}Ra$
por: Hourani, E, et al.
Publicado: (1991)

(223)Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice
por: Dizdarevic, Sabina, et al.
Publicado: (2018)

Temperature effects on alpha radioactivity of $^{223}$Ra
por: Huber, Gerhard, et al.
Publicado: (2006)

Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases
por: Kapoor, Anil, et al.
Publicado: (2019)

Fine structure in 14C emission from 223Ra and 224Ra
por: Hourani, E, et al.
Publicado: (1991)

Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with (223)Ra: PARABO, a Prospective, Noninterventional Study
por: Palmedo, Holger, et al.
Publicado: (2023)

Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
por: Uemura, Hiroji, et al.
Publicado: (2017)

Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease
por: Harrison, Michael R, et al.
Publicado: (2013)

The role of dosimetry and biological effects in metastatic castration–resistant prostate cancer (mCRPC) patients treated with (223)Ra: first in human study
por: Sciuto, Rosa, et al.
Publicado: (2021)

The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study)
por: Bauckneht, Matteo, et al.
Publicado: (2021)

(177)Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior (223)Ra (RALU Study)
por: Rahbar, Kambiz, et al.
Publicado: (2023)

Radium-223 in metastatic castration resistant prostate cancer
por: Vuong, Winston, et al.
Publicado: (2014)

Radium-223 for the treatment of castration-resistant prostate cancer
por: El-Amm, Joelle, et al.
Publicado: (2015)

$^{223}$Ra nuclear spectroscopy in $^{14}$C cluster radioactivity
por: Hourany, E, et al.
Publicado: (1995)

Radiobiological effects of the alpha emitter Ra-223 on tumor cells
por: Bannik, Kristina, et al.
Publicado: (2019)

A simple route for renewable nano-sized arjunolic and asiatic acids and self-assembly of arjuna-bromolactone
por: Bag, Braja G, et al.
Publicado: (2008)

Ru-catalyzed dehydrogenative coupling of carboxylic acids and silanes - a new method for the preparation of silyl ester
por: Liu, Guo-Bin, et al.
Publicado: (2008)

DBFOX-Ph/metal complexes: Evaluation as catalysts for enantioselective fluorination of 3-(2-arylacetyl)-2-thiazolidinones
por: Ishimaru, Takehisa, et al.
Publicado: (2008)

Synthesis of new triazole-based trifluoromethyl scaffolds
por: Martinelli, Michela, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_io7649nkj2u8bvjpvkl7o4g0fu